Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Timothy A. Johnson Medical Scholar Lecture presented by the Fralin Biomedical Research Institute at VTC and the Virginia Tech Carilion School of Medicine
Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Date: Nov. 6, 2020
Time: 1:00 p.m. - 2:00 p.m.
Talk Abstract
Dr. Sheehan will describe her career as a physician scientist, and how her laboratory uses genomics to unravel the mechanisms of globin switching and the pharmacogenomics of hydroxyurea in SCD, in order to develop new fetal hemoglobin inducing agents to treat people with sickle cell disease. Her work has led to a clinical trial of metformin as a fetal hemoglobin inducing agent in patients with hemoglobinopathies. Dr. Sheehan has also developed rheology biomarkers for use in assessing cure in gene based therapy, and collaborates with Dr. Gang Bao to assess the safety and efficacy of CRISPR /Cas9 based gene therapy in SCD.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and the Virginia Tech Carilion School of Medicine. The Timothy A. Johnson Medical Scholar Lecture Series hosts clinician scientists who are exploring frontiers of medicine. These lectures are principally intended for Virginia Tech Carilion School of Medicine students and Virginia Tech students in Translational Biology, Medicine, and Health graduate program. Virginia Tech and Carilion Clinic faculty, staff, and students may also attend.
You May Also Be Interested In...
-
Home Item
Policies to Reduce Ultra-processed Foods: Lessons From Around the Globe , homeJan. 30, 2026, 11:00 a.m. | Lindsey Smith Taillie, Ph.D., MPH, Associate Professor of Nutrition, Associate Chair of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home Item
AI and Agentic AI: Opportunities for How We Work, Care, Discover, and Share , homeFeb. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Vivian S. Lee, M.D., Ph.D., M.B.A., Executive Fellow, Harvard Business School; Senior Lecturer, Harvard Medical School; Elected Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
Early Childhood Brain Development and Risk for Schizophrenia , homeFeb. 13, 2026, 11 a.m. | John Gilmore, M.D., Eure Distinguished Professor and Vice Chair for Research, Department of Psychiatry, University of North Carolina School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home Item
Is It What You Eat or When You Eat? Evidence for Time Restricted Eating in Humans , homeFeb. 27, 2026, 11:00 a.m. | Lisa Chow, M.D., Professor of Medicine, Pennock Family Land Grant Chair in Diabetes Research, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
A Nicotine-Focused Regulatory Strategy: The Science , homeMarch 13, 2026, 11:00 a.m. | Dorothy Hatsukami, Ph.D., Professor of Psychiatry and Behavioral Sciences and Forster Family Chair in Cancer Prevention, Masonic Cancer Center, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
Vivien Sheehan, M.D., Ph.D.
Associate Professor of Pediatrics, and Director of Translational Sickle Cell Disease Research at the Emory University School of Medicine